Select Page
Event info
Date:30 Mar
Time:09:00 - 16:30
Venue:MVA, Copenhagen S

New updates in Drug Formulation & Bioavailability

Formulation and bioavailability are critical steps in the development process of new effective drugs. One reason for failure in clinical trials might be explained by poor formulation and bioavailability properties of the drug. Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about these topics at this meeting featureing about 100 delgates and 12 exhibitors. The event will be covered by the press.

Date: March 30, 2016
Time: 09.00 – 16.30
Place: Medicon Valley Alliance, Copenhagen S
Adress: Edvard Thomsens Vej 14, Ørestad
Cost: Free

Read more here

SIGN UP HERE

Information

New updates in Drug Formulation & Bioavailability is a platform that based on the concept of synergies between “science” and “business”. The presented content and topics will focus on advancements in formulations and cutting edge technologies that can allow cheaper, safer and effective drugs.

Real life case studies from experts detailing practical advice and best practice for all formulation and delivery specialists. Presented by subject matter experts, these sessions will provide you with the ideal opportunity not only to learn from a real case, but also, examine and exchange views on key industry challenges in a more informal setting.

Exhibition with over 10 leading solution providers is the most efficient and cost effective way to identify the latest technologies to support your formulation and delivery requirements. Suppliers will be showcasing products that could significantly increase your efficiency & profitability.

The target audience consists of:

  • Drug formulation professionals from Big Pharma, CDMO’s, Academia
  • Early Phase & virtual biotech and pharma companies
  • QA & Reg Aff. Managers
  • Procurement Managers

Speakers will come from:

Pharmaceutical companies, Excipient manufacturers, CDMO’s, Academia

Topics will include:

  • Formulation development design space
  • Improving bioavailability of poorly soluble compounds
  • Controlled and modified release technologies
  • Out-sourcing and in-licensing
  • Exploring different routes of administration in enhancing macromolecule delivery

For more info and for questions about exhibiting and speaking opportunities please contact Program Director Maria Eriksson on +46(0)8670 41 86 or maria.eriksson@mentoronline.se

In collaboration with:

logo Kemivarldenbiotech